Identification of a new target of miR-16, vacuolar protein sorting 4a

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Adhikari, Neeta ^a   Guan, Weihua ^b   Capaldo, Brian ^c   Mackey, Aaron J ^c   Carlson, Marjorie ^a   Ramakrishnan, Sundaram ^b   Walek, Dinesha ^b   Gupta, Manu ^d   Mitchell, Adam ^a   Eckman, Peter ^a   John, Ranjit ^a   Ashley, Euan ^e   Barton, Paul J ^f   Hall, Jennifer L ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^e STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^f NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 107; MICRORNA 15; MICRORNA 16; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG; VACUOLAR PROTEIN SORTING 4A; 3' UNTRANSLATED REGION; ESCRT PROTEIN; MICRORNA; MIRN16 MICRORNA, HUMAN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; VPS4A PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; BINDING SITE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FUNCTION; GENOTYPE; HEART FAILURE; HUMAN; IN VITRO STUDY; LEFT VENTRICULAR ASSIST DEVICE; MALE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; BIOSYNTHESIS; BLOOD; CELL LINE; GENETICS; HEART ASSIST DEVICE; HEART MUSCLE; HEK293 CELL LINE; MIDDLE AGED; PATHOLOGY; VALIDATION STUDY;

3' UNTRANSLATED REGIONS; AGED; BINDING SITES; CELL LINE; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HEK293 CELLS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MYOCARDIUM; POLYMORPHISM, SINGLE NUCLEOTIDE; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 84904498001     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101509     Document Type: Article

References (29)

1. Haas U, Sczakiel G, Laufer SD (2012) MicroRNA-mediated regulation of gene expression is affected by disease-associated SNPs within the 39-UTR via altered RNA structure. RNA Biol 9: 924-937.
2. Clop A, Marcq F, Takeda H, Pirottin D, Tordoir X, et al. (2006) A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet 38: 813-818. (Pubitemid 43980603)
3. Subkhankulova T, Gilchrist MJ, Livesey FJ (2008) Modelling and measuring single cell RNA expression levels find considerable transcriptional differences among phenotypically identical cells. BMC Genomics 9: 268.
4. Mullokandov G, Baccarini A, Ruzo A, Jayaprakash AD, Tung N, et al. (2012) High-throughput assessment of microRNA activity and function using micro-RNA sensor and decoy libraries. Nat Methods 9: 840-846.
5. Larsson E, Sander C, Marks D (2010) mRNA turnover rate limits siRNA and microRNA efficacy; Larsson E, Sander C, Marks D, editors.
6. Day L, Abdelhadi Ep Souki O, Albrecht AA, Steinhöfel K (2013) Accessibility of microRNA binding sites in metastable RNA secondary structures in the presence of SNPs. Bioinformatics.
7. Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, et al. (2010) Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease. Circulation: Cardiovascular Genetics 3: 499-506.
8. Devaux Y, Vausort M, McCann GP, Kelly D, Collignon O, et al. (2013) A Panel of 4 microRNAs Facilitates the Prediction of Left Ventricular Contractility after Acute Myocardial Infarction. PLoS ONE 8: e70644.
9. Fichtlscherer S, Zeiher AM, Dimmeler S (2011) Circulating MicroRNAs: Biomarkers or Mediators of Cardiovascular Diseases? Arteriosclerosis, Thrombosis, and Vascular Biology 31: 2383-2390.
10. Fukushima Y, Nakanishi M, Nonogi H, Goto Y, Iwai N (2011) Assessment of Plasma miRNAs in Congestive Heart Failure. Circulation Journal 75: 336-340.
11. Tijsen AJ, Creemers EE, Moerland PD, de Windt LJ, van der Wal AC, et al. (2010) MiR423-5p As a Circulating Biomarker for Heart Failure. Circulation Research 106: 1035-1039.
12. Merkerova M, Belickova M, Bruchova H (2008) Differential expression of microRNAs in hematopoietic cell lineages. European Journal of Haematology 81: 304-310.
13. Finnerty JR, Wang W-X, Hébert SS, Wilfred BR, Mao G, et al. (2010) The miR-15/107 Group of MicroRNA Genes: Evolutionary Biology, Cellular Functions, and Roles in Human Diseases. Journal of Molecular Biology 402: 491-509.
14. Bandi N, Zbinden S, Gugger M, Arnold M, Kocher V, et al. (2009) miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Res 69: 5553-5559.
15. Cai CK, Zhao GY, Tian LY, Liu L, Yan K, et al. (2012) miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma. Oncol Rep 28: 1764-1770.
16. Rissland Olivia S, Hong S-J, Bartel DP (2011) MicroRNA Destabilization Enables Dynamic Regulation of the miR-16 Family in Response to Cell-Cycle Changes. Molecular Cell 43: 993-1004.
17. Linsley PS, Schelter J, Burchard J, Kibukawa M, Martin MM, et al. (2007) Transcripts Targeted by the MicroRNA-16 Family Cooperatively Regulate Cell Cycle Progression. Molecular and Cellular Biology 27: 2240-2252. (Pubitemid 46418479)
18. Goretti E, Rolland-Turner M, Léonard F, Zhang L, Wagner DR, et al. (2013) MicroRNA-16 affects key functions of human endothelial progenitor cells. Journal of Leukocyte Biology 93: 645-655.
19. Hill CP, Babst M (2012) Structure and function of the membrane deformation AAA ATPase Vps4. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1823: 172-181.
20. Mitchell A, Guan W, Staggs R, Hamel A, Hozayen S, et al. (2013) Identification of Differentially Expressed Transcripts and Pathways in Blood One Week and Six Months Following Implant of Left Ventricular Assist Devices. PLoS One 8: e77951.
21. Cotsapas C, Prokunina-Olsson L, Welch C, Saxena R, Weaver C, et al. (2010) Expression analysis of loci associated with type 2 diabetes in human tissues. Diabetologia 53: 2334-2339.
22. Adhikari N, Basi DL, Townsend D, Rusch M, Mariash A, et al. (2010) Heparan sulfate Ndst1 regulates vascular smooth muscle cell proliferation, vessel size and vascular remodeling. Journal of Molecular and Cellular Cardiology 49: 287-293.
23. Wang X, Adhikari N, Li Q, Guan Z, Hall JL (2004) The Role of β-Transducin Repeat-Containing Protein (β-TrCP) in the Regulation of NF-κB in Vascular Smooth Muscle Cells. Arteriosclerosis, Thrombosis, and Vascular Biology 24: 85-90. (Pubitemid 38082416)
24. Basi DL, Adhikari N, Mariash A, Li Q, Kao E, et al. (2007) Femoral artery neointimal hyperplasia is reduced after wire injury in Ref-1+/- mice. Am J Physiol Heart Circ Physiol 292: H516-521. (Pubitemid 46105215)
25. Balakrishnan A, Stearns AT, Park PJ, Dreyfuss JM, Ashley SW, et al. (2010) MicroRNA mir-16 is anti-proliferative in enterocytes and exhibits diurnal rhythmicity in intestinal crypts. Experimental Cell Research 316: 3512-3521.
26. Chamorro-Jorganes A, Araldi E, Penalva LOF, Sandhu D, Fernández-Hernando C, et al. (2011) MicroRNA-16 and MicroRNA-424 Regulate Cell-Autonomous Angiogenic Functions in Endothelial Cells via Targeting Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1. Arteriosclerosis, Thrombosis, and Vascular Biology 31: 2595-2606.
27. Chen L, Wang Q, Wang G-D, Wang H-S, Huang Y, et al. (2013) miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma. FEBS letters 587: 1366-1372.
28. Lezina L, Purmessur N, Antonov AV, Ivanova T, Karpova E, et al. (2013) miR-16 and miR-26a target checkpoint kinases Wee1 and Chk1 in response to p53 activation by genotoxic stress. Cell Death Dis 4: e953.
29. Preskill C, Weidhaas JB (2013) SNPs in MicroRNA Binding Sites as Prognostic and Predictive Cancer Biomarkers. 18: 327-340.